Menk Mario, Graw Jan Adriaan, von Haefen Clarissa, Sifringer Marco, Schwaiberger David, Unger Thomas, Steckelings Ulrike, Spies Claudia D
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany,
Inflammation. 2015 Aug;38(4):1690-9. doi: 10.1007/s10753-015-0146-9.
Recently, AT2 receptors have been discovered on the surface of human immunocompetent cells such as monocytes. Data on regulative properties of this receptor on the cellular immune response are poor. We hypothesized that direct stimulation of the AT2 receptor mediates anti-inflammatory responses in these cells. Human monocytic THP-1 and U937 cells were stimulated with lipopolysaccharide (LPS) and the selective AT2 receptor agonist Compound 21 (C21). Expression of pro- and anti-inflammatory cytokines IL-6, IL-10, tumor necrosis factor-α (TNFα), and IL-1β were analyzed on both the transcriptional and the translational level over course of time. Treatment with C21 attenuated the expression of TNFα, IL-6, and IL-10 after LPS challenge in both cell lines in a time- and dose-dependent manner. We conclude that selective AT2 receptor stimulation acts anti-inflammatory in human monocytes. Modulation of cytokine response by AT2 receptor activation might be a beneficial and novel treatment concept in inflammatory conditions.
最近,在人类免疫活性细胞(如单核细胞)表面发现了血管紧张素Ⅱ2型(AT2)受体。关于该受体对细胞免疫反应调节特性的数据较少。我们推测,直接刺激AT2受体可介导这些细胞的抗炎反应。用脂多糖(LPS)和选择性AT2受体激动剂化合物21(C21)刺激人单核细胞白血病细胞系THP-1和U937细胞。在一段时间内,从转录和翻译水平分析促炎和抗炎细胞因子白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNFα)和白细胞介素-1β(IL-1β)的表达。在两种细胞系中,用C21处理均可在LPS刺激后,以时间和剂量依赖性方式减弱TNFα、IL-6和IL-10的表达。我们得出结论,选择性刺激AT2受体在人单核细胞中具有抗炎作用。通过激活AT2受体来调节细胞因子反应可能是炎症性疾病一种有益的新治疗理念。